Novartis AG ADR [NVS] stock is trading at $103.41, up 3.44%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NVS shares have gain 6.03% over the last week, with a monthly amount glided 5.04%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on December 04, 2024, when HSBC Securities downgraded its rating to a Reduce. Previously, BofA Securities downgraded its rating to Neutral on September 11, 2024, and dropped its price target to $130. On September 05, 2024, downgrade downgraded it’s rating to Neutral. Jefferies downgraded its rating to a Hold. Deutsche Bank downgraded its rating to a Hold. Goldman started tracking with a Buy rating for this stock on May 30, 2024, and assigned it a price target of $120. In a note dated February 23, 2024, BMO Capital Markets initiated an Market Perform rating and provided a target price of $114 on this stock.
Novartis AG ADR [NVS] stock has fluctuated between $92.35 and $120.92 over the past year. Currently, Wall Street analysts expect the stock to reach $120.5 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $103.41 at the most recent close of the market. An investor can expect a potential return of 16.53% based on the average NVS price forecast.
Analyzing the NVS fundamentals
Novartis AG ADR [NYSE:NVS] reported sales of 48.59B for the trailing twelve months, which represents a growth of 8.84%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.25%, and Net Profit Margin reading is 0.35%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.41 and Total Capital is 0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.74.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 102.46 points at the first support level, and at 101.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 103.93, and for the 2nd resistance point, it is at 104.44.
Ratios To Look Out For
For context, Novartis AG ADR’s Current Ratio is 1.11. Also, the Quick Ratio is 0.90, while the Cash Ratio stands at 0.48. Considering the valuation of this stock, the price to sales ratio is 4.16, the price to book ratio is 4.77 and price to earnings (TTM) ratio is 12.06.
Transactions by insiders
Recent insider trading involved Kowalski Robert William, Officer, that happened on Aug 12 ’24 when 6566.0 shares were purchased.
